The medtech sector is important for the Swiss economy and a driving force for business, innovation, and healthcare. This was confirmed by the latest industry study published by Swiss Medtech and the Helbling Group.

It is not only medicines that are in short supply in Switzerland, but also medical devices. Swiss innovations also migrate to the USA. Neither is necessary. Implement Motion 20.3211 now and approve FDA products. 

Despite their great potential, robotic assistance systems are underused. Improved framework conditions and appropriate reimbursement are needed to increase access.

Together with other members of the Alliance for Digital Transformation in Healthcare, Swiss Medtech is calling for an independent remuneration model for digital healthcare applications. 

Switzerland is making a new attempt to stabilise and further develop bilateral relations with the European Union (EU). In the ticker Europe, economiesuisse analyses current developments.

The current call has the topic of AI in the life sciences with a focus on human health. Consortia can submit their pre-proposals until 12 November.